金城医药(300233.SZ)与中国药科大学签署《共建“女性健康药物创新中心”框架协议》

智通财经09-27

智通财经APP讯，金城医药(300233.SZ)公告，公司近日与中国药科大学签署了《共建“女性健康药物创新中心”框架协议》。双方依托金城医药先进的现代化生产技术和女性健康产品品牌优势以及中国药科大学的人才优势与产品开发研究技术基础，整合校企优势资源，聚焦女性健康，进行药物研发与创新。据悉，双方将以建设“女性健康药物创新中心”为目标，定位女性健康药物的长效制剂、改良型新药和创新药的研发。经双方共同...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2470773836?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-09-27 15:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2470773836","market":"us","top_or_hot":-1,"title":"金城医药(300233.SZ)与中国药科大学签署《共建“女性健康药物创新中心”框架协议》","media":"智通财经","content":"<div>\n<p>智通财经APP讯，金城医药(300233.SZ)公告，公司近日与中国药科大学签署了《共建“女性健康药物创新中心”框架协议》。双方依托金城医药先进的现代化生产技术和女性健康产品品牌优势以及中国药科大学的人才优势与产品开发研究技术基础，整合校企优势资源，聚焦女性健康，进行药物研发与创新。据悉，双方将以建设“女性健康药物创新中心”为目标，定位女性健康药物的长效制剂、改良型新药和创新药的研发。经双方共同...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1188082.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>金城医药(300233.SZ)与中国药科大学签署《共建“女性健康药物创新中心”框架协议》</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n金城医药(300233.SZ)与中国药科大学签署《共建“女性健康药物创新中心”框架协议》\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-27 15:57 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1188082.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，金城医药(300233.SZ)公告，公司近日与中国药科大学签署了《共建“女性健康药物创新中心”框架协议》。双方依托金城医药先进的现代化生产技术和女性健康产品品牌优势以及中国药科大学的人才优势与产品开发研究技术基础，整合校企优势资源，聚焦女性健康，进行药物研发与创新。据悉，双方将以建设“女性健康药物创新中心”为目标，定位女性健康药物的长效制剂、改良型新药和创新药的研发。经双方共同...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1188082.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FHCO","symbol_name":"女性健康","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1188082.html","article_id":"2470773836","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2470773836","pubTimestamp":1727423873,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，金城医药(300233.SZ)公告，公司近日与中国药科大学签署了《共建“女性健康药物创新中心”框架协议》。双方依托金城医药先进的现代化生产技术和女性健康产品品牌优势以及中国药科大学的人才优势与产品开发研究技术基础，整合校企优势资源，聚焦女性健康，进行药物研发与创新。据悉，双方将以建设“女性健康药物创新中心”为目标，定位女性健康药物的长效制剂、改良型新药和创新药的研发。经双方共同讨论，结合项目的成熟度，初步筛选了首批拟合作项目，包括黄体酮长效注射剂、黄体酮阴道缓释凝胶等项目。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300233":"金城医药","FHCO":"女性健康","BK0028":"国家队","BK0239":"医药制造"},"translate_title":"Jincheng Pharmaceutical (300233. SZ) and China Pharmaceutical University signed the \"Framework Agreement on Jointly Building the\" Women's Health Drug Innovation Center \"\"","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300233":1,"FHCO":1},"content_text":"智通财经APP讯，金城医药(300233.SZ)公告，公司近日与中国药科大学签署了《共建“女性健康药物创新中心”框架协议》。双方依托金城医药先进的现代化生产技术和女性健康产品品牌优势以及中国药科大学的人才优势与产品开发研究技术基础，整合校企优势资源，聚焦女性健康，进行药物研发与创新。据悉，双方将以建设“女性健康药物创新中心”为目标，定位女性健康药物的长效制剂、改良型新药和创新药的研发。经双方共同讨论，结合项目的成熟度，初步筛选了首批拟合作项目，包括黄体酮长效注射剂、黄体酮阴道缓释凝胶等项目。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2470773836"}